Remus Pharmaceuticals Ltd Share Price

NSEBSE

₹1,865

(0.11%)

Jun 18, 2025|02:55:16 PM

Invest wise with Expert advice

Equities

Futures

Option

Open₹1,863
Day's High₹1,865
52 Wk High₹2,834.75
Prev. Close₹1,862.9
Day's Low₹1,863
52 Wk Low ₹1,785.1

Turnover (lac)3.73
P/E55.16
Face Value₹10
Book Value₹0
EPS33.77
Mkt. Cap (Cr.)₹1,098.86
Div. Yield0

View All Historical Data

No Records Found

View More Options

Remus Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹1,863

Prev. Close

₹1,862.9

Turnover(Lac.)

₹3.73

Day's High

₹1,865

Day's Low

₹1,863

52 Week's High

₹2,834.75

52 Week's Low

₹1,785.1

Book Value

₹0

Face Value

₹10

Mkt Cap (₹ Cr.)

1,098.86

P/E

55.16

EPS

33.77

Divi. Yield

Remus Pharmaceuticals Ltd Corporate Action

29 Aug 2024

12:00 AM

AGM

Announcement Date: 29 Aug, 2024

12 May 2025

12:00 AM

Board Meeting

Agenda : Audited Result

Remus Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

Knowledge Center

Demat Account

Trading Account

Remus Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

18 Jun, 2025|03:13 PM

Mar-2025 Sep-2024 Jun-2024 Mar-2024

Foreign Promoter
Indian Promoter
Institutions
Non Institutions
Custodies

Promoter- 70.85%

Foreign: 0.00%

Indian: 70.85%

Non-Promoter- 5.54%

Institutions: 5.54%

Non-Institutions: 23.60%

Custodian: 0.00%

Remus Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

ConsolidatedStandalone

GraphTable

Y/e 31 Mar( In .Cr)	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Equity Capital	1.47	1.09	1	0.01
Preference Capital	0	0	0	0
Reserves	80.59	18.05	5.58	3.13
Net Worth	82.06	19.14	6.58	3.14
Minority Interest

No Record Found

No Record Found

No Record Found

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Mar-2025	Mar-2024
Gross Sales	620.36	212.94
Excise Duty	0	0
Net Sales	620.36	212.94
Other Operating Income	0	0
Other Income	4.98	2.83

View Annually Results

Remus Pharmaceuticals Ltd Peer Comparison

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceutical Industries Ltd SUNPHARMA	1,650.2	92.37	3,95,614.35	2,000.46	0.97	7,107.14	101.44
Divis Laboratories Ltd DIVISLAB	6,538	78.56	1,73,532.83	667	0.46	2,536	561.08
Cipla Ltd CIPLA	1,503.5	24.66	1,21,436.24	1,485.4	1.06	4,254.47	397.42
Dr Reddys Laboratories Ltd DRREDDY	1,318.8	20.58	1,10,068.12	1,200.7	0.61	5,546.3	345.79
Torrent Pharmaceuticals Ltd TORNTPHARM	3,255.4	57.76	1,10,060.9	474	0.98	2,385	224.33

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Remus Pharmaceuticals Ltd

Management

Register Office

Registrar Office

No Record Found

Registered Office

1101 to 1103 South Tower One42,

B/H Ashok Vatika Amblibopal Rd,

Gujarat - 380054

Tel: 91-079-29999857

Website: https://www.remuspharma.com

Email: cs@remuspharma.com

Registrar Office

C-101 247 Park,

L B S Marg, Vikhroli West,

Mumbai-400083

Tel: 91-22-49186000

Website: www.linkintime.co.in

Email: paytm.ipo@linkintime.co.in

Summary

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by t...
Read More

Reports by Remus Pharmaceuticals Ltd

Company FAQs

What is the Remus Pharmaceuticals Ltd share price today?

The Remus Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1865 today.

What is the Market Cap of Remus Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Remus Pharmaceuticals Ltd is ₹1098.86 Cr. as of 18 Jun ‘25

What is the PE and PB ratio of Remus Pharmaceuticals Ltd?

The PE and PB ratios of Remus Pharmaceuticals Ltd is 55.16 and 4.53 as of 18 Jun ‘25

What is the 52 Week High and Low of Remus Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Remus Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Remus Pharmaceuticals Ltd is ₹1785.1 and ₹2834.75 as of 18 Jun ‘25

What is the CAGR of Remus Pharmaceuticals Ltd?

Remus Pharmaceuticals Ltd's CAGR for 5 Years at N/I%, 3 Years at 60.66%, 1 Year at -9.40%, 6 Month at -22.78%, 3 Month at -6.61% and 1 Month at -12.09%.

What is the shareholding pattern of Remus Pharmaceuticals Ltd?

The shareholding pattern of Remus Pharmaceuticals Ltd is as follows:
Promoters - 70.85 %
Institutions - 5.54 %
Public - 23.60 %

QUICKLINKS FOR Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Ltd Share Price

Equities

Futures

Option

Remus Pharmaceuticals Ltd KEY RATIOS

Remus Pharmaceuticals Ltd Corporate Action

Remus Pharmaceuticals Ltd NEWS AND UPDATE

Knowledge Center

Demat Account

Trading Account

Remus Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

Promoter- 70.85%

Non-Promoter- 5.54%

Remus Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Remus Pharmaceuticals Ltd Peer Comparison

MORE ABOUT Remus Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Company FAQs

QUICKLINKS FOR Remus Pharmaceuticals Ltd

Information

Financials

Results

News

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES